CAMBRIDGE, Mass. & OAKLAND, Calif.--(BUSINESS WIRE)--ViaCord®, the umbilical cord blood preservation division of ViaCell, Inc. (Nasdaq: VIAC), and Children’s Hospital Oakland Research Institute (CHORI) today announced that they have achieved their 100th umbilical cord blood transplant. The 100th transplant was a sibling transplant to treat Severe Combined Immunodeficiency (SCID), commonly known as “bubble boy” disease. This historic milestone includes transplants through cord blood collected, preserved and stored with ViaCord and transplants using cord blood stored through CHORI’s Sibling Donor Cord Blood Program.
